Abstract

BackgroundBody composition alterations, or lipodystrophy, can lead to serious health problems in people living with HIV/AIDS (PLWHA). The objectives of this study are to predict and validate sex-specific anthropometric predictive models for the diagnosis of lipodystrophy in PLWHA.MethodsA cross-sectional design was employed to recruit 106 PLWHA (men = 65 and women = 41) in Brazil during 2013–2014. They were evaluated using dual-energy X-ray absorptiometry, and 19 regions of body perimeters and 6 skinfold thicknesses were taken. Sex-specific predictive models for lipodystrophy diagnosis were developed through stepwise linear regression analysis. Cross-validations using predicted residual error sum of squares was performed to validate each predictive model.ResultsResults support the use of anthropometry for the diagnosis of lipodystrophy in men and women living with HIV/AIDS. A high power of determination with a small degree of error was observed for lipodystrophy diagnosis for men in model six (r2 = 0.77, SEE = 0.14, r2PRESS = 0.73, SEE PRESS = 0.15), that included ratio of skinfold thickness of subscapular to medial calf, skinfold thickness of thigh, body circumference of waist, formal education years, time of diagnosis to HIV months, and type of combined antiretroviral therapy (cART) (with protease inhibitor “WI/PI = 1” or without protease inhibitor “WO/PI = 0”); and model five for women (r2 = 0.78, SEE = 0.11, r2PRESS = 0.71, SEE PRESS = 0.12), that included skinfold thickness of thigh, skinfold thickness of subscapular, time of exposure to cART months, body circumference of chest, and race (Asian) (“Yes” for Asian race = 1; “No” = 0).ConclusionsThe proposed anthropometric models advance the field of public health by facilitating early diagnosis and better management of lipodystrophy, a serious adverse health effect experienced by PLWHA.

Highlights

  • Body composition alterations, or lipodystrophy, can lead to serious health problems in people living with human immunodeficiency virus (HIV)/AIDS (PLWHA)

  • As a result of combined antiretroviral therapy (cART) treatment, today the life expectancy of people living with HIV/AIDS has increased 37 years [5]

  • Our study proposes to fill this gap in the literature by developing anthropometric models to predict and subsequently validate lipodystrophy diagnoses for men and women living with HIV/ AIDS

Read more

Summary

Introduction

Lipodystrophy, can lead to serious health problems in people living with HIV/AIDS (PLWHA). Low- and middle-income countries, primarily in Africa and Latin America,. A few decades ago, people living with HIV/AIDS (PLWHA) were given a short life expectancy. At the peak of the HIV epidemic between 1990 and 2000, life expectancy for PLWHA dropped to 49.5 years in some low- and middle-income countries; HIV and AIDS (acquired immunodeficiency syndrome) combined, decreased life expectancy by approximately 20 years [2]. CART is the current standard treatment for HIV [3]. As a result of cART treatment, today the life expectancy of people living with HIV/AIDS has increased 37 years [5]. Around 53% of all people living with HIV have access to treatment [1]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call